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Abstract. 
 
Microinjection of human Jurkat T-lympho-
cytes with nicotinic acid adenine dinucleotide phos-
 
phate (NAADP
 
1
 
) dose-dependently stimulated intra-
 
cellular Ca
 
2
 
1
 
-signaling. At a concentration of 10 nM 
 
NAADP
 
1
 
 evoked repetitive and long-lasting Ca
 
2
 
1
 
-
 
oscillations of low amplitude, whereas at 50 and 100 nM, 
a rapid and high initial Ca
 
2
 
1
 
-peak followed by trains of 
smaller Ca
 
2
 
1
 
-oscillations was observed. Higher concen-
trations of NAADP
 
1
 
 (1 and 10 
 
m
 
M) gradually reduced 
the initial Ca
 
2
 
1
 
-peak, and a complete self-inactivation 
of Ca
 
2
 
1
 
-signals was seen at 100 
 
m
 
M. The effect of 
NAADP
 
1
 
 was speciﬁc as it was not observed with nico-
tinamide adenine dinucleotide phosphate. Both inositol 
1,4,5-trisphosphate– and cyclic adenosine diphosphori-
bose–mediated Ca
 
2
 
1
 
-signaling were efﬁciently inhib-
ited by coinjection of a self-inactivating concentration 
of NAADP
 
1
 
. Most importantly, microinjection of a 
self-inactivating concentration of NAADP
 
1
 
 completely 
abolished subsequent stimulation of Ca
 
2
 
1
 
-signaling via 
the T cell receptor/CD3 complex, indicating that a func-
tional NAADP
 
1
 
 Ca
 
2
 
1
 
-release system is essential for
T-lymphocyte Ca
 
2
 
1
 
-signaling.
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Introduction
 
Activation of T-lymphocytes via the T cell receptor/CD3
(TCR/CD3)
 
1
 
 complex results in multiple intracellular sig-
naling pathways (Kennedy et al., 1999). Among these
pathways, an elevation of [Ca
 
2
 
1
 
]
 
i
 
 (intracellular Ca
 
2
 
1
 
-con-
centration) is essential for proliferation and clonal expan-
sion (reviewed in Guse, 1998). The increase of [Ca
 
2
 
1
 
]
 
i
 
 in T
cells consists of calcium release from intracellular stores,
and, as a major source for the long-lasting Ca
 
2
 
1
 
-signal ob-
served in T cells, subsequent entry of calcium through spe-
cific calcium channels in the plasma membrane (reviewed
in Guse, 1998). Ca
 
2
 
1
 
-release is activated by the calcium
 
mobilizing second messengers 
 
D
 
-
 
myo
 
-inositol 1,4,5-tris-
phosphate(Ins(1,4,5)P
 
3
 
) and cyclic ADP-ribose (cADPR).
Recent work indicates that Ins(1,4,5)P
 
3
 
 primarily acts dur-
ing the initial phase of Ca
 
2
 
1
 
-signaling in T cells, whereas
cADPR is essentially involved in the sustained phase of
Ca
 
2
 
1
 
-signaling (Guse et al., 1999).
Besides Ins(1,4,5)P
 
3
 
 and cADPR, another Ca
 
2
 
1
 
-mobiliz-
ing natural compound, nicotinic acid adenine dinucleotide
phosphate (NAADP
 
1
 
) was introduced (Chini et al., 1995;
Lee and Aarhus, 1995). NAADP
 
1
 
 was originally discov-
ered as a contaminant of commercial nicotinamide ade-
nine dinucleotide phosphate (NADP
 
1
 
) preparations; such
preparations could also be enriched in NAADP
 
1
 
 content
by alkaline treatment (Clapper et al., 1987). Very low con-
centrations of NAADP
 
1
 
 in the range of 10–50 nM were
shown to effectively release Ca
 
2
 
1
 
 from intracellular stores
of selected invertebrate and mammalian cell types, such as
sea urchin eggs (Lee and Aarhus, 1995), ascidian oocytes
(Albrieux et al., 1998), and mouse pancreatic acinar cells
(Cancela et al., 1999). NAADP
 
1
 
-mediated Ca
 
2
 
1
 
-release
 
was not sensitive to the cADPR antagonist, 8-NH
 
2
 
-cADPR;
 
the Ins(1,4,5)P
 
3
 
 antagonist, heparin (Lee and Aarhus, 1995);
or to the antagonists of ryanodine receptors (RyR),
procaine or ruthenium red (Chini et al., 1995). Together,
with the lack of cross-desensitization observed between
the NAADP
 
1
 
/Ca
 
2
 
1
 
-release system on one hand, and the
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D
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cADPR/- or the Ins(1,4,5)P
 
3
 
/Ca
 
2
 
1
 
-release systems on the
other hand (Chini et al., 1995; Lee and Aarhus, 1995),
these data indicate that the NAADP
 
1
 
-dependent Ca
 
2
 
1
 
-
release system is different from the two others. Although
the receptor for NAADP
 
1
 
 has not yet been identified,
unspecific effects of NAADP
 
1
 
 are largely unlikely since
concrete structural requirements for NAADP
 
1
 
-mediated
Ca
 
2
 
1
 
-release were demonstrated in sea urchin eggs, e.g.,
the NH
 
2
 
-group at position 6 of the adenine ring or the
phosphate group at the 2
 
9
 
-position of the ribose are neces-
sary (Lee and Aarhus, 1997). The latter can be replaced by
a 3
 
9
 
-phosphate or a 2
 
9
 
,3
 
9
 
-cyclic phosphate, but this alteration
resulted in a weaker Ca
 
2
 
1
 
-release activity (Lee and Aar-
hus, 1997). Further characteristic properties of NAADP
 
1
 
-
mediated Ca
 
2
 
1
 
-release in sea urchin eggs are a unique self
inactivation or self desensitization process (Aarhus et al.,
1996; Genazzani et al., 1996), and Ca
 
2
 
1
 
-release from a
thapsigargin-insensitive Ca
 
2
 
1
 
-pool (Genazzani and Galione,
1996).
The fact that recent reports indicated a role for
NAADP
 
1
 
 in Ca
 
2
 
1
 
-signaling of mammalian cells (Bak et al.,
1999; Cancela et al., 1999) prompted us to study its effects
in human Jurkat T cells. We report here that NAADP
 
1
 
specifically and dose-dependently stimulated Ca
 
2
 
1
 
-sig-
naling when microinjected into intact Jurkat T cells.
Furthermore, we show that self inactivation of the
NAADP
 
1
 
/Ca
 
2
 
1
 
-release system almost completely inhib-
ited Ins(1,4,5)P
 
3
 
- or cADPR-mediated Ca
 
2
 
1
 
-signaling.
Most importantly, we demonstrate that self inactivation of
the NAADP
 
1
 
/Ca
 
2
 
1
 
-release also completely antagonized
Ca
 
2
 
1
 
-signaling mediated by ligation of the TCR/CD3-
complex.
 
Materials and Methods
 
Reagents
 
cADPR, 8-OCH
 
3
 
-cADPR, and 
 
D
 
-
 
myo
 
-inositol 1,4,6-trisphosphorothioate
(Ins(1,4,6)PS
 
3
 
) were synthesized exactly as described (Ashamu et al.,
1995; Murphy et al., 2000), purified by anion-exchange chromatography
on Q-Sepharose, and used as their triethylammonium salts. Purity of
ligands was assessed by 
 
1
 
H and 
 
31
 
P NMR spectroscopy, mass spectroscopy,
and, when appropriate, HPLC. NAADP
 
1
 
 and NADP
 
1
 
 were purchased
from Sigma-Aldrich. The purity of NAADP
 
1
 
 was described by the manu-
facturer to be 
 
z
 
95%; this was confirmed by reverse phase HPLC using
the method of da Silva et al. (1998). Fura 2/AM was obtained from Cal-
biochem. Anti-CD3 mAb OKT3 was purified from hybridoma superna-
tant on protein G–Sepharose.
 
Cell Culture
 
Jurkat T lymphocytes (subclone JMP) were cultured in RPMI 1640 me-
dium containing the following additions: glutamax I, Hepes (20 mM, pH
7.4), NCS (7.5%), penicillin (100 U/ml), and streptomycin (50 
 
m
 
g/ml; all
obtained from Life Technologies). The cells were cultured at 37
 
8
 
C in a hu-
midified atmosphere in the presence of 5% CO
 
2
 
.
 
Ratiometric Ca
 
2
 
1
 
 Imaging
 
Batches of 10
 
7
 
 Jurkat T cells were loaded with Fura2/AM as described
(Guse et al., 1993). Fura2-loaded cells (10
 
7
 
 cells/5 ml) were kept at room
temperature until use. Glass coverslips were coated first with BSA (5
mg/ml), and then with poly-
 
L
 
-lysine (0.1 mg/ml). Small chambers consist-
ing of a rubber O-ring were sealed on the coverslips by silicon grease.
Then, 90 
 
m
 
l of extracellular buffer (140 mM NaCl, 5 mM KCl, 1 mM
MgSO
 
4
 
, 1 mM CaCl
 
2
 
, 20 mM Hepes, 1 mM NaH
 
2
 
PO
 
4
 
, 5.5 mM glucose, pH
 
7.4) was added, followed by addition of 10 
 
m
 
l cell suspension. The cover-
slip was mounted on the stage of an inverted microscope (Axiovert 100,
ZEISS). Ratiometric Ca
 
2
 
1
 
 imaging was performed using a PhotoMed/
Photon Technology (Wedel) digital imaging system built around the Ax-
iovert 100 microscope. Illumination at 340 and 380 nm was carried out us-
ing a chopper/optical filter system. Images were captured by an intensified
CCD camera (type C2400-77; spatial resolution: 525 
 
3
 
 487 pixel;
Hamamatsu) and stored as individual 340 and 380 images on hard disk.
Sampling rate was usually 5 s for a pair of images (340 and 380 nm) using
100-fold magnification. Data analysis was performed off-line using Pho-
toMed/Photon Technology (Wedel) Image master analysis software. Ra-
tio images (340/380) were constructed pixel by pixel, and changes in the
ratio over time were measured by applying regions-of-interest on individ-
ual cells. Finally, ratio values were converted to Ca
 
2
 
1-concentrations by
external calibration.
Microinjection Experiments
Parallel Ca21 imaging and microinjection experiments require a firm at-
tachment of the Jurkat T cells without preactivation of intracellular Ca21-
signaling. This was achieved by the above mentioned coating procedure of
the glass coverslips, as detailed earlier (Guse et al., 1997). The cells were
kept in a small chamber (100 ml vol) in extracellular buffer (140 mM NaCl,
5 mM KCl, 1 mM MgSO4, 1 mM CaCl2, 20 mM Hepes, 1 mM NaH2PO4,
5.5 mM glucose, pH 7.4). Compounds to be microinjected were cleared
from particles by either filtration through 0.45-mm filters, by centrifuga-
tion in an Eppendorf centrifuge at maximal speed for 10 min, or by both.
Femtotips II (Eppendorf) were filled with 5 ml of reagent solution and in-
serted into the semiautomatic microinjection system (Transjector 5246,
Micromanipulator 5171, Eppendorf). Injection parameters were: injection
pressure, 80 hPa; compensatory pressure, 40 hPa; duration of injection.
0.5 s; velocity of pipette, 700 mm/s; pipette angle, 458. Injections were per-
formed into the upper part of the cell.
Results
Microinjection of NAADP1 at a pipette concentration as
low as 10 nM stimulated repetitive, long-lasting Ca21-spik-
ing of low amplitude in intact Jurkat T cells, whereas injec-
tion of intracellular buffer alone had no effect (Fig. 1, A,
B, E, and F). Microinjection of 0.1 or 1 nM NAADP1 was
without effect in most of the cells (Fig. 1, C and D, and
data not shown). At a pipette concentration of 50 nM
NAADP1, an initial, rapidly occurring Ca21-peak with a
high amplitude was observed which turned into gradually
lowering oscillations during the first 350–400 s. After this
time period, the calcium response changed into a low, but
sustained, plateau phase with very small oscillations (Fig.
1, G and H). At pipette concentrations of 100 nM and 1 mM,
similar responses were observed (Fig. 1, I–L). However,
the peak amplitude of the initial Ca21-spike declined with
increasing NAADP1 concentrations (Fig. 1, J and L), and
the decay of the Ca21-signal was accelerated (Fig. 1 H, J,
and L). At 10 mM NAADP1, the Ca21-response appeared
similar to the one at 1 nM (Fig. 1, M and N), whereas at
100 mM NAADP1, no signal was detectable (Fig. 1, O and
P). The dose response relationship shows a bell-shaped
curve for the initial Ca21-peak with an optimal NAADP1
concentration at 100 nM (Fig. 2 A). However, only minor
changes of the long-lasting Ca21-signal as measured at 400 s
were observed in response to 100 nM NAADP1 (Fig. 2 B).
These data indicate that, similar to the few other cellular
systems investigated so far (Chini et al., 1995; Lee and
Aarhus, 1995; Albrieux et al., 1998; Cancela et al., 1999),
NAADP1 at low nanomolar concentrations activates
Ca21-signaling in T cells, whereas micromolar concentra-
tions of NAADP1 rapidly cause self inactivation of the
Ca21-release system.Berg et al. NAADP1: A Regulator for T Cell Ca21-signaling 583
The high initial Ca21-spike observed after microinjection
of 50 nM NAADP1 was massively reduced when the ex-
tracellular Ca21-concentration was decreased to a nominal
Ca21-free buffer, indicating that Ca21-entry is involved in
the NAADP1-mediated Ca21-response (data not shown).
To prove the specificity of the effect of NAADP1 on in-
tracellular Ca21-signaling in T cells, NADP1 was used in
parallel microinjection experiments. NADP1 is a structur-
ally similar molecule, bearing a nicotinamide group in-
stead of the nicotinic acid group. In contrast to NAADP1,
microinjection of NADP1 (50 nM) was completely with-
out effect on Ca21-signaling (Fig. 3, A and B).
The Ca21-release system that is targeted by NAADP1
has not yet been identified, but work in other cell systems
indicates that neither the Ins(1,4,5)P3 receptor (InsP3-R)
nor the RyR are involved (Chini et al., 1995; Lee and Aar-
hus, 1995). However, both of these classical intracellular
Ca21-release systems have been demonstrated to be essen-
tial parts of the Ca21-signaling machinery of T cells (Ja-
yaraman et al., 1995; Guse et al., 1999). Thus, the next se-
ries of experiments was designed to investigate potential
interrelations between the NAADP1 system on one hand
and both the Ins(1,4,5)P3 and cADPR systems on the
other.
The specific cADPR antagonist 8-OCH3-cADPR (Guse
et al., 1999), when coinjected with an optimal NAADP1
concentration, did not significantly affect NAADP1-medi-
ated Ca21-signaling (Fig. 4, A and F vs. B and G). How-
ever, when a self-desensitizing concentration of NAADP1
(10 mM) was coinjected with a stimulating concentration
of cADPR (10 mM), a massive decrease of the cADPR-
mediated Ca21-signal was observed (Fig. 4, C and H vs. E
and J). On the other hand, an optimal stimulating concen-
tration of NAADP1 (50 nM) microinjected together with
Figure 1. Concentration-response curves of Ca21
signals in single intact T-lymphocytes microinjected
with NAADP1. Jurkat T-lymphocytes were loaded
with Fura2/AM and Ca21 was measured as detailed
in Materials and Methods. Cells were injected as de-
scribed in Materials and Methods in the presence of
1 mM extracellular Ca21. Data are presented as
overlays of single tracings of individual cells (left).
The right shows the corresponding averages from
these measurements (number of cells displayed,
n 5 5–17). As a control, vehicle buffer without
NAADP1 was injected (A and B). The time points
of microinjection are indicated by arrows.
Figure 2. Dose-response curve for NAADP1 in Jurkat T cells.
Data from Fig. 1 are shown as mean values (n 5 5–17) from time
point 80 s (Ca21-peak; A) or 400 s (Ca21-plateau; B).The Journal of Cell Biology, Volume 150, 2000 584
cADPR (10 mM) did not significantly change the Ca21-sig-
nals (Fig. 4, D and I vs. E and J). These data indicate that a
functional, nondesensitized NAADP1/Ca21-release sys-
tem is necessary for cADPR-mediated Ca21-release.
The specific Ins(1,4,5)P3 antagonist, Ins(1,4,6)PS3 (Guse
et al., 1997; Murphy et al., 2000), was also coinjected with
an optimal NAADP1 concentration. Surprisingly, there
was a partial reduction of the initial Ca21-peak, but also a
faster decay of this peak as compared with injection of
NAADP1 alone (Fig. 5, A and F vs. B and G). Similar to
the cADPR system, there was an almost complete inhibi-
tion of Ins(1,4,5)P3-mediated Ca21-release when a desensi-
tizing concentration of NAADP1 was coinjected (Fig. 5, C
and H). Coinjection of an optimal stimulating concentra-
tion of NAADP1, together with Ins(1,4,5)P3, resulted in a
high initial Ca21-peak (Fig. 5, D and I) that was compara-
ble to the peak observed in response to injection of
NAADP1 alone (Fig. 5, B and C), whereas much less os-
cillatory activity of the cells after the initial peak was ob-
served (Fig. 5, D and I) as compared with Ins(1,4,5)P3
alone (Fig. 5, E and J). These data also indicate that
the Ins(1,4,5)P3/Ca21-release system requires a functional
nondesensitized NAADP1/Ca21-release system. More-
over, a part of the Ca21-signal observed in response to
microinjection of NAADP1 alone appears to be medi-
ated by Ins(1,4,5)P3 (Fig. 5, A, F, B, and G). This may
be explained by the coagonistic effect of Ca21 released
by NAADP1, which then acts together with basal
Ins(1,4,5)P3 at the InsP3-R; this coagonistic effect of Ca21
at the InsP3-R has been demonstrated previously (Bez-
prozvanny et al., 1991).
Both the Ins(1,4,5)P3/Ca21- and the cADPR/Ca21-
Figure 3. NADP1 does not mediate Ca21-signaling. Jur-
kat T-lymphocytes were loaded with Fura2/AM and ra-
tiometric Ca21 imaging, and parallel microinjection in
the presence of 1 mM extracellular Ca21 was carried out
as detailed under Materials and Methods. Cells were in-
jected with 50 nM NAADP1 (A) or NADP1 (B).
Shown are the averages from 13 (A) and 5 (B) cells. The
time points of microinjection are indicated by arrows.
Figure 4. Influence of cADPR and its antagonist
8-OCH3-cADPR on NAADP1-mediated Ca21-sig-
naling. Jurkat T-lymphocytes were loaded with
Fura2/AM, and ratiometric Ca21 imaging and par-
allel microinjection in the presence of 1 mM extra-
cellular Ca21 was carried out as detailed under Mate-
rials and Methods. Left, Overlays of single tracings
of individual cells after injection (A–E); right, dem-
onstrates the corresponding averages from these
overlays (F–J). Shown are (n 5 number of experi-
ments): A/F, coinjection of NAADP (50 nM) and
8-OCH3-cADPR (100 mM; n 5 7); B/G, injection of
NAADP1 (50 nM, n 5 10); C/H, coinjection of
NAADP1 (10 mM) and cADPR (10mM; n 5 7); D/I,
coinjection of NAADP1 (50 nM) and cADPR (10
mM; n 5 5); and E/J, injection of cADPR (10 mM,
n 5 5).Berg et al. NAADP1: A Regulator for T Cell Ca21-signaling 585
release systems have been published to be essential parts
of the Ca21-signaling machinery of T cells upon stimula-
tion of the TCR/CD3 complex (Jayaraman et al., 1995;
Guse et al., 1999). Since the data described above indicate
that a functional NAADP1/Ca21-release system is essen-
tial for both Ins(1,4,5)P3- and cADPR-mediated Ca21-
release, we investigated the effect of NAADP1 on Ca21-
signaling mediated by anti-CD3 mAb OKT3 (Fig. 6). Mi-
croinjection of 50 nM NAADP1 before stimulation of the
cells by extracellular addition of OKT3 did not signifi-
cantly change the OKT3-mediated Ca21-signal (Fig. 6, A
and B). However, there was a dramatic inhibition of
OKT3-mediated Ca21-signaling when a desensitizing con-
centration of NAADP1 was microinjected before stimula-
tion by OKT3 (Fig. 6 C).
Discussion
The main findings of this report are: a dose-dependent and
specific effect of NAADP1 in T cell Ca21-signaling; the
strict dependence of both Ins(1,4,5)P3- and cADPR-medi-
ated Ca21-release upon a functional NAADP1/Ca21-
release system; and inhibition of Ca21-signaling mediated
by ligation of the TCR/CD3 complex by prior self inactiva-
tion of the NAADP1/Ca21-release system.
In sea urchin eggs, Ca21-release by NAADP1 was half-
maximal between 16 and 30 nM, and showed saturation
between z100 and 400 nM (Chini et al., 1995; Lee and
Aarhus, 1995). In ascidian oocytes and mouse pancreatic
acinar cells, effective concentrations between 10 and 50 nM
were observed (Albrieux et al., 1998; Cancela et al., 1999),
although in brain microsomes 1 mM NAADP1 was neces-
sary (Bak et al., 1999). These data fit very well to our cur-
rent data in Jurkat T cells, the first human cell system
where an effect of NAADP1 is reported. Ca21-mobilizing
concentrations were in the range between 10 and 100 nM
(Figs. 1 and 2), whereas at concentrations $1 mM, partial
or complete self inactivation was observed (Figs. 1 and 2).
The self inactivation properties of the NAADP1/Ca21-
release system, at least in sea urchin eggs, appear to be
unique as compared with the known Ca21-mobilizing sec-
ond messengers, Ins(1,4,5)P3 and cADPR (Aarhus et al.,
1996; Genazzani et al., 1996). Especially the fact that sub-
threshold concentrations of NAADP1 (2 to 4 nM) almost
completely inhibited subsequent Ca21-release by a high
concentration of NAADP1 (Aarhus et al., 1996; Genaz-
zani et al., 1996) indicates that activation of the NAADP1/
Ca21-release system followed by its rapid inactivation can
supply the cell with a short pulse of elevated Ca21 only,
and that the basal endogenous concentration of NAADP1
must be below a concentration that would permanently in-
activate the system, e.g., in sea urchin eggs below 0.1 nM
Figure 5. Influence of Ins(1,4,5)P3 and its antagonist
Ins(1,4,6)PS3 on NAADP1-mediated Ca21-signaling.
Jurkat T-lymphocytes were loaded with Fura2/AM,
and ratiometric Ca21 imaging and parallel microin-
jection in the presence of 1 mM extracellular Ca21
was carried out as detailed under Materials and
Methods. Left, Overlays of single tracings of individ-
ual cells after injection (A–E); right, demonstrates
the corresponding averages from these overlays (F–
J). Shown are: A/F, coinjection of NAADP1 (50
nM) and Ins(1,4,6)PS3 (40 mM; n 5 7); B/G, injection
of NAADP1 (50 nM; n 5 10); C/H, coinjection of
NAADP1 (10 mM) and Ins(1,4,5)P3 (4 mM; n 5 9);
D/I, coinjection of NAADP1 (50 nM) and
Ins(1,4,5)P3 (4 mM;  n 5 3); and E/J injection of
Ins(1,4,5)P3 (4 mM; n 5 8).The Journal of Cell Biology, Volume 150, 2000 586
(Aarhus et al., 1996) or even less (Genazzani et al., 1996).
Data in mammalian cell types, pancreatic acinar cells
(Cancela et al., 1999), and T cells, however, indicate that
low concentrations of NAADP1 do not substantially self-
inactivate the system, e.g., microinjections of 10 nM
NAADP1 in the majority of cases stimulated long-lasting
trains of low-amplitude Ca21-spikes in T cells (Fig. 1 E),
and infusion of 50 nM NAADP1 into acinar cells evoked
sustained Ca21-spiking (Cancela et al., 1999).
To completely unravel the role of NAADP1, mainly to
verify (or to falsify) its status as a second messenger, mea-
surement of the endogenous concentration of NAADP1
would be helpful. However, regarding the theoretically ex-
pected concentrations of #0.1 nM in unstimulated cells
and 50–100 nM NAADP1 in stimulated cells, it might be
very difficult to develop an analytical system to measure
these low concentrations. Our recently developed HPLC
systems for the mass determination of Ins(1,4,5)P3 (Guse
et al., 1995) and cADPR (da Silva et al., 1998) require
0.5–1 3 108 cells per sample to measure these compounds
in the low micromolar range. To measure basal NAADP1
concentrations a 1,000-fold more sensitive analytical
method would be required. Potential methods to achieve
this may include labeling of NAADP1 by a fluorescent
dye (pre- or postcolumn derivatization) combined with a
very sensitive fluorescence detector, e.g., laser-induced
fluorescence detection (Rahavendran and Karnes, 1993).
Alternatively, a competitive protein binding assay based
on a high affinity binding protein for NAADP1 may also
be sufficient.
As discussed above, regarding the NAADP1/Ca21-
release system, there are similarities between mouse pan-
creatic acinar cells and human T cells, e.g., a very similar
dose-response relationship for NAADP1, and the fact that
self inactivation of the NAADP1/Ca21-release renders
both cell types insensitive to physiological stimulation.
However, there are also at least three clear differences
between the two cell systems: inhibition of either the
cADPR/Ca21-release system or the Ins(1,4,5)P3/Ca21-
release system in pancreatic acinar cells completely
blocked NAADP1-mediated Ca21-signaling (Cancela et
al., 1999), whereas similar inhibition protocols were with-
out or almost without effect in T cells; self inactivation of
the NAADP1/Ca21-release system did not influence Ca21-
signaling mediated by infusion of cADPR or Ins(1,4,5)P3
in acinar cells (Cancela et al., 1999), whereas in T cells
such self-inactivation of the NAADP1/Ca21-release sys-
tem almost completely inhibited subsequent signaling by
cADPR or Ins(1,4,5)P3; and in acinar cells, the sustained
phase of Ca21-spiking induced by infusion of cADPR
could be blocked by the Ins(1,4,5)P3 antagonist heparin
(Thorn et al., 1994), whereas in T cells there was no effect
of the Ins(1,4,5)P3 antagonist, Ins(1,4,6)PS3, on cADPR-
mediated Ca21-signaling (Guse et al., 1997).
Using the data obtained from pancreatic acinar cells, Pe-
tersen and Cancela (1999) developed a model with the fol-
lowing sequence of events: stimulation of acinar cells by
the brain–gut peptide, cholecystokinin, in first instance
elevates NAADP1 to nanomolar concentrations. Ca21 re-
leased by NAADP1 then serves as a trigger for the Ca21-
induced Ca21-release mechanism at the RyR. This mecha-
nism, in addition to the stimulatory effect of cADPR on
RyR, then amplifies the Ca21-signal. The increased [Ca21]i
in concert with Ins(1,4,5)P3 then releases more Ca21 via
the InsP3-R (Petersen and Cancela, 1999). Only this last
element is measurable as a Ca21-spike, whereas the trig-
ger and amplifier element, provided by NAADP1 and
the Ca21-induced Ca21-release mechanism modulated by
cADPR, appear to be too small to be detected by patch
clamp measurements of the Ca21-dependent currents (Pe-
tersen and Cancela, 1999).
In contrast to acinar cells, in Jurkat T cells NAADP1
produced a substantial Ca21-spike, even if cADPR- and
Ins(1,4,5)P3-antagonists were present (Figs. 4, A and F,
and 5, A and F). The second main difference to acinar cells
was that in Jurkat T cells, Ca21-signaling by cADPR and
Ins(1,4,5)P3 depended on a functional NAADP1/Ca21-
release system (Figs. 4, C and H, and 5, C and H). Al-
though two different methods were used to detect the Ca21-
spikes: patch clamp measurements of the Ca21-dependent
currents vs. single cell Ca21 imaging using Fura2-loaded
cells, this is unlikely to be the reason for the differences
observed. Thus, the model developed for the acinar cells
(Petersen and Cancela, 1999) needs some modification to
fit to the data obtained in Jurkat T cells. In accordance
with the acinar cell model, NAADP1 appears to act first
in sequence providing trigger-calcium needed for the
two other Ca21-release systems. Because of the experi-
mental difficulties to measure nanomolar concentrations
of NAADP1 in cells as discussed above, it is unclear whether
Figure 6. Effect of NAADP1 on OKT3-induced Ca21-signaling
in single Jurkat T-lymphocytes. Jurkat T-lymphocytes were
loaded with Fura2/AM, and ratiometric Ca21 imaging and paral-
lel microinjection in the presence of 1 mM extracellular Ca21 was
carried out as detailed under Materials and Methods. The cells
were injected with different concentrations of NAADP1 and
then OKT3 (10 mg/ml) was added. Injection of intracellular
buffer (A), NAADP1 (50 nM [B] and 10 mM [C]), and addition
of OKT3 is indicated by arrows. Data are presented as a typical
tracing from one individual cell; for each condition at least three
experiments were carried out.Berg et al. NAADP1: A Regulator for T Cell Ca21-signaling 587
NAADP1 concentrations in fact do increase upon stimula-
tion, or whether NAADP1 stays unaltered in the low nano-
molar range keeping the T cell in an excitable state. Exper-
imental evidence for the latter may be obtained by high
temporal and spatial resolution Ca21 imaging experi-
ments in Jurkat T cells; preliminary data indicate a basal
Ca21-signaling activity of very low amplitude in nonstimu-
lated cells (Guse, A.H., and S. Heidbrink, unpublished re-
sults). However, trigger-calcium provided by NAADP1
further acts in concert with Ins(1,4,5)P3, which is rapidly,
but transiently, formed in the first minutes of T cell activa-
tion (Brattsand et al., 1990; Ng et al., 1990), and then with
cADPR, which is elevated during the sustained phase of T
cell Ca21-signaling (Guse et al., 1999).
However, despite these differences between acinar and
T cells the dependence of cholecystokinin receptor–medi-
ated Ca21-signaling on a Ca21-trigger supplied by an ini-
tial NAADP1-mediated Ca21-release event to inte-
grate  the Ca21-amplifier, cADPR, and the Ca21-oscillator,
Ins(1,4,5)P3 (Petersen and Cancela, 1999), exactly mirrors
the situation observed in Jurkat T cells. As shown in Fig. 6,
if the NAADP1/Ca21-release system was inactivated by
high NAADP1 concentrations subsequent quasiphysio-
logical stimulation of the T cell by anti-CD3 mAb did not
result in any Ca21-signaling. This result is in complete ac-
cordance with the inhibition of cADPR- or Ins(1,4,5)P3-
mediated Ca21-signaling by coinjection of NAADP1
(Figs. 4, C and H, and 5, C and H) since Ca21-signaling in
T cells critically depends on these two second messengers
(Jayaraman et al., 1995; Guse et al., 1999).
More generalized, if the NAADP1/Ca21-release system
acts as the Ca21-providing trigger, the complex behavior
of activation and inactivation opens a multitude of regula-
tory possibilities: simply by changing their endogenous
NAADP1 concentration cells might regulate the status of
the NAADP1/Ca21-release system; e.g., by increasing
NAADP1 the NAADP1/Ca21-release system will become
inactivated, and Ca21-signaling will in turn be completely
unresponsive. For T-lymphocytes, such behavior of unre-
sponsiveness to antigenic or mitogenic stimulation is well
known as anergy (Jenkins et al., 1987); however, it is less
clear which intracellular mechanism is responsibly in-
volved. Our data indicate that the NAADP1/Ca21-release
system with its complex inactivation/activation properties
might be such a mechanism underlying anergy in T cells.
From an evolutionary point of view, it is of particular in-
terest that both a very similar dose-response relationship
and the self inactivation property of the NAADP1/Ca21-
release have been conserved between sea urchin eggs, as-
cidian oocytes, and higher eukaryotic cells from pancreas
and lymphocytes. This indicates that these two characteris-
tic features are of outstanding importance for the regula-
tion of intracellular Ca21-signaling in general. One of the
important future aspects will be the identification of the
molecular target for NAADP1. In addition to the model
for pancreatic acinar cells (Cancela et al., 1999; Petersen
and Cancela, 1999) in which a separate NAADP1 recep-
tor has been suggested, it might also be possible that
NAADP1 acts as a comessenger at the known intracellular
Ca21-release channels, the Ins(1,4,5)P3 receptor and/or
the RyR. Along these lines, the fluorescent 1,N6-etheno-
NAADP1 has been shown to release Ca21 in sea urchin
eggs (Lee and Arhus, 1998), and thus, may serve as a tool
to identify the receptor for NAADP1.
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